Cargando…

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial

INTRODUCTION: Sarcoidosis is a granulomatous systemic disease that becomes chronic in approximately one third of affected patients resulting in quality of life and functional impairment. Immunosuppressive drugs other than steroids represent alternative therapeutic options, but side effects like live...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frye, Björn C., Rump, Ina Caroline, Uhlmann, Annette, Schubach, Fabian, Ihorst, Gabriele, Grimbacher, Bodo, Zissel, Gernot, Quernheim, Joachim Müller
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292904/ https://www.ncbi.nlm.nih.gov/pubmed/32551397 http://dx.doi.org/10.1016/j.conctc.2020.100575

Ejemplares similares

The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
por: Krausz, Máté, et al.
Publicado: (2022)

FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients
por: Frye, Björn Christian, et al.
Publicado: (2021)

Translation and psychometric properties of the King’s Sarcoidosis Questionnaire (KSQ) in German language
por: Farin, Erik, et al.
Publicado: (2019)

Psychometric properties of the German version of the Leicester Cough Questionnaire in sarcoidosis
por: Schupp, Jonas Christian, et al.
Publicado: (2018)

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas
por: Plönes, Till, et al.
Publicado: (2012)

CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive Potential
por: Ploenes, Till, et al.
Publicado: (2013)

Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
por: Stahl, Mirjam, et al.
Publicado: (2013)

CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II
por: Pechkovsky, Dmitri V, et al.
Publicado: (2005)

Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II
por: Höhne, Kerstin, et al.
Publicado: (2012)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis
por: Seitzer, Ulrike, et al.
Publicado: (2002)

Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis
por: Müller-Quernheim, J.
Publicado: (1996)

Analysis of single nucleotide polymorphisms in chronic beryllium disease
por: Frye, Björn C., et al.
Publicado: (2021)

Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice
por: Almogairen, Sultan M.
Publicado: (2019)

Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP
por: Scherr, Benedikt F., et al.
Publicado: (2023)

Novel Approach in Cardiac Sarcoidosis: A Case Report Highlighting Abatacept as a Promising Treatment Option
por: Venkataraj, Maamannan, et al.
Publicado: (2023)

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients
por: Freitag-Wolf, Sandra, et al.
Publicado: (2023)

Immune response to Propionibacterium acnes in patients with sarcoidosis – in vivo and in vitro
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations
por: Kishore, Amit, et al.
Publicado: (2016)

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2017)

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
por: Gkika, Eleni, et al.
Publicado: (2018)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

Bronchoalveolar Lavage Fluid Reflects a T(H)1-CD21(low) B-Cell Interaction in CVID-Related Interstitial Lung Disease
por: Friedmann, David, et al.
Publicado: (2021)

Subcutaneous abatacept for the treatment of rheumatoid arthritis
por: Schiff, Michael
Publicado: (2013)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Subcutaneous Abatacept vErsus Intravenous Abatacept: A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
por: Genovese, M C, et al.
Publicado: (2011)

Sex differences in the genetics of sarcoidosis across European and African ancestry populations
por: Xiong, Ying, et al.
Publicado: (2023)

Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2008)

Abatacept as a Therapeutic Option for Rheumatoid Vasculitis
por: Al Attar, Layth, et al.
Publicado: (2018)

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
por: Schiff, Michael, et al.
Publicado: (2011)

Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes
por: Gámez-Díaz, Laura, et al.
Publicado: (2021)

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
por: Truchetet, Marie-Elise, et al.
Publicado: (2016)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
por: Köller, Marcus D.
Publicado: (2007)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

Abatacept in psoriatic arthritis: Case report and short review
por: Ursini, Francesco, et al.
Publicado: (2013)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Lutt, Joseph R
Publicado: (2009)

Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t6j81ap96eu7mlqr1o8moqbv0i